| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5594301 | American Heart Journal | 2017 | 9 Pages |
Abstract
A novel CHAN2T3 biomarker score could supplement risk-based discussion for ASCVD prevention, especially when treatment decision is uncertain. Further validation in other cohorts is however warranted
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Emmanuel MD, MPH, Alexandros MD, PhD, Luis MD,